Standardisation of Curcuminoids into More Bioavailable form (CurcuminAura™) and Its Pharmacokinetics
Srikrishna Lingadahalli Puttachar *
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Vinisha Mascarenhas
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Aliya Mohammad Sayed
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Desiree Delicia Fernandes
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Teja Moreshwar Godkar
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Shawna Reyhan Correia
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Saisha Ningappa Patil
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Sebastian Thomas
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Savitha B Pillai
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Sahil Naik
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
Sakshi Murlidhar Naik
Innovation Centre, DSIR Approved, Department of Research and Development, Verna Industrial Estate, Goa, India and Bio-Med Ingredients Private Limited, Verna, Goa, India.
*Author to whom correspondence should be addressed.
Abstract
Curcuminoids are naturally occurring phytocompound extracted from the turmeric rhizome Curcuma longa, a member of the ginger (Zingiberaceae) family. Through the development of a trademark product called Bio-Curcumin, this study seeks to increase the bioavailability and absorption of regular marketed curcumin by 95%. This finding has important implications for the academic and scientific community. The pharmacokinetic study of CurcuminAura™ and its innovation of biocurcuminoids is detailed in detail. Innovation of BioCurcuminoids and its Pharmacokinetic Study of CurcuminAura™ with regular curcuminoids is significantly described which is the need of the hour. This enhanced sunflower lecithin is an effective ingredient in the trademark product CurcuminAuraTM, which was created by Bio-Med Ingredients Pvt.Ltd. Its potency in the market can be increased by lecithin's capacity to efficiently encapsulate active substances, improve bioavailability, and increase absorption. Regular curcumin's weak solubility and poor absorption in its free form. Regular Curcumin due to its poor solubility and poor absorption in the free form in the gastrointestinal tract and its rapid biotransformation to inactive metabolites can greatly limit its utility as a health-promoting agent and dietary supplement. Hence to make it more readily available in the body. CurcuminovaTM is developed will enhance the properties of Curcumin making it more potent in the market. The Evaluation of the Comparative Pharmacokinetic Study of CurcuminAuraTM with Marketed Curcumin 95.0% was carried out through pre-clinical investigations in Sprague Dawley Rats via Oral Route which is the aim of this study with two groups in the study design, with four rats of each sex. Oral administration of CurcuminAuraTM and Curcumin 95.0% was administered to rats in the G1 and G3 groups, respectively. A dosage volume of 10 milliliters per kilogram of body weight was maintained for the oral route. After Dosage, under isofluorane,the blood samples were taken from the retroorbital sinuses after the dose was administered under varying periods of anaesthesia. Animals were split up into two sets for each group, and blood samples were taken at 30-, 2-, and 4-hour intervals. Samples were taken for analysis after being kept at -800C. Designed to increase the bioavailability of curcuminoids, CurcuminAuraTM is standardized to 60.9% total curcuminoids by HPLC, as opposed to marked conventional curcumin 95%. This has been confirmed by HPLC analysis. According to comparison studies, CurcuminAuraTM has a bioavailability that is 3.8 times greater than the reference standard. Additionally, in this study it is shown that the maximum absorption happens in the timeline 3 hrs after feeding the drug.
Keywords: CurcuminAura™, curcumin, zingiberaceae, sunflower lecithin, pharmacokinetics, bioavailability